
    
      A Phase 3, multicenter, prospective, randomized, double-blind, efficacy and safety study of
      Rezafungin for Injection versus an active comparator regimen of caspofungin followed by
      optional oral fluconazole step-down therapy in subjects with candidemia and/or invasive
      candidiasis.
    
  